326
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Development of a Standardized Scoring System to Assess a Murine Model of Clostridium difficile Colitis

, , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rita D. Shelby, Grace E. Janzow, Lauren Mashburn-Warren, Jeffrey Galley, Natalie Tengberg, Jason Navarro, Miriam Conces, Michael T. Bailey, Steven D. Goodman & Gail E. Besner. (2020) A novel probiotic therapeutic in a murine model of Clostridioides difficile colitis. Gut Microbes 12:1.
Read now

Articles from other publishers (12)

Yoko Tanaka, Sho Tashiro, Shintaro Ikegami, Yuki Enoki, Kazuaki Taguchi & Kazuaki Matsumoto. (2023) Oral teicoplanin administration suppresses recurrence of Clostridioides difficile infection: Proof of concept. Anaerobe 84, pages 102789.
Crossref
Jinqiu Liu, Wei Zhu, Duncan James Lessing & Weihua Chu. (2023) Synthetic microbial consortia for the treatment of Clostridioides difficile infection in mice model . Microbial Biotechnology.
Crossref
Sho Tashiro, Kazuaki Taguchi, Yuki Enoki & Kazuaki Matsumoto. (2023) Antimicrobial Efficacy Evaluations of Metronidazole against Clostridioides difficile Infection using Fecal Pharmacokinetic and Pharmacodynamic Analyses. Pharmaceutical Research 40:7, pages 1799-1806.
Crossref
Sho Tashiro, Kazuaki Taguchi, Yuki Enoki & Kazuaki Matsumoto. (2023) Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation models. Clinical Microbiology and Infection 29:5, pages 616-622.
Crossref
Elvin Koh, In Young Hwang, Hui Ling Lee, Ryan De Sotto, Jonathan Wei Jie Lee, Yung Seng Lee, John C. March & Matthew Wook Chang. (2022) Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism. Nature Communications 13:1.
Crossref
Mecklin V. Ragan, Samantha J. Wala, Steven D. Goodman, Michael T. Bailey & Gail E. Besner. (2022) Next-Generation Probiotic Therapy to Protect the Intestines From Injury. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Akhil A. Vinithakumari, Piyush Padhi, Belen Hernandez, Susanne Je-Han Lin, Aaron Dunkerson-Kurzhumov, Lucas Showman, Matthew Breitzman, Caroline Stokes, Yousuf Sulaiman, Chandra Tangudu, Deepa A. Kuttappan, Muhammed S. Muyyarikkandy, Auriel A. Willette, Gregory J. Phillips, Vellareddy Anantharam, Ann Perera, Brett A. Sponseller, Anumantha Kanthasamy & Shankumar Mooyottu. (2022) Clostridioides difficile Infection Dysregulates Brain Dopamine Metabolism. Microbiology Spectrum 10:2.
Crossref
Shahrbanoo Keshavarz Azizi Raftar, Fatemeh Ashrafian, Sara Abdollahiyan, Abbas Yadegar, Hamid Reza Moradi, Morteza Masoumi, Farzam Vaziri, Arfa Moshiri, Seyed Davar Siadat & Mohammad Reza Zali. (2022) The anti-inflammatory effects of Akkermansia muciniphila and its derivates in HFD/CCL4-induced murine model of liver injury. Scientific Reports 12:1.
Crossref
Abraham Joseph Pellissery, Poonam Gopika Vinayamohan, Deepa Ashwarya Kuttappan, Neha Mishra, Breno de Oliveira Fragomeni, Kendra Maas, Shankumar Mooyottu & Kumar Venkitanarayanan. (2021) Protective Effect of Baicalin against Clostridioides difficile Infection in Mice. Antibiotics 10:8, pages 926.
Crossref
Radek Sleha, Vera Radochova, Alexander Mikyska, Milan Houska, Radka Bolehovska, Sylva Janovska, Jaroslav Pejchal, Lubica Muckova, Pavel Cermak & Pavel Bostik. (2021) Strong Antimicrobial Effects of Xanthohumol and Beta-Acids from Hops against Clostridioides difficile Infection In Vivo. Antibiotics 10:4, pages 392.
Crossref
L. Cussó, E. Reigadas, P. Muñoz, Manuel Desco & E. Bouza. (2019) Evaluation of Clostridium difficile Infection with PET/CT Imaging in a Mouse Model. Molecular Imaging and Biology 22:3, pages 587-592.
Crossref
Felix Broecker, Erik Wegner, Bruna M. S. Seco, Paulina Kaplonek, Maria Bräutigam, Armin Ensser, Frederick Pfister, Christoph Daniel, Christopher E. Martin, Jochen Mattner & Peter H. Seeberger. (2019) Synthetic Oligosaccharide-Based Vaccines Protect Mice from Clostridioides difficile Infections . ACS Chemical Biology 14:12, pages 2720-2728.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.